Gainesville, Florida - Quick-Med Technologies Inc. has announced that it had been awarded a grant of approximately $770000 by the US Army to develop a prototype wound dressing for speeding up healing from chemical blister agents.
The wound dressing, the company said, would be based on its Nimbus technology, which created a permanent chemical bond to materials such as polyurethane, cotton or paper.
Quick-Med was awarded the Phase II of US Army's Small Business Innovative Research program for up to two years includes an additional $40000 under Phase I, which the company completed earlier.
"The potential use of our Nimbus technology in a wound dressing for the military has exciting and novel commercial applications," Quick-Med president David Lerner said.
Quick-Med also said that it had extended its Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of Chemical Defense and Technologies until 30 June 2011.
The CRADA was originally signed on 15 Nov 2000 to develop a post-injury agent to treat eyes and skin exposed to mustard gas.